CDK8-IN-7 (compound 12) 是一种有效的选择性细胞周期蛋白依赖性激酶 8 (CDK8)抑制剂，Kd为 3.5 nM。CDK8-IN-7 对 MOLM-13、OCI-AML3、MV4-11、NRK 和 H9c2 细胞具有细胞毒性，IC50s 分别为 5.9、4.8、5.4、16.2、12.5-25 μM。CDK8-IN-7 具有研究AML-癌症的潜力。

CDK8-IN-7 (compound 12) is a potent and selective cyclin-dependent kinase 8 (CDK8) inhibitor with an K d of 3.5 nM. CDK8-IN-7 shows cytotoxicity for MOLM-13, OCI-AML3, MV4-11, NRK and H9c2 cells with IC 50 s of 5.9, 4.8, 5.4, 16.2, 12.5-25 μM, respectively. CDK8-IN-7 has the potential for the research of AML-cancer [1].

2415156-30-6

C30H40N2

428.65

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years